Experimental Psilocybin Treatment Shows Temporary Improvement in Alzheimer's Patient
An 80-year-old Alzheimer's patient experienced temporary improvements in speech, continence, and memory following a single dose of psilocybin, the active component in magic mushrooms. The patient, who had been in cognitive decline for a decade, showed remarkable progress after receiving a 5-gram dose. Initially, the patient exhibited agitation and entered a prolonged sleep state, but later began speaking in full sentences and recalling past events. Over the following weeks, the patient regained urinary continence and improved social interactions. A subsequent 3-gram dose further enhanced verbal expression and mobility. Despite these improvements, the effects were temporary, and the underlying neurodegeneration remained. The study highlights the potential of psilocybin in accessing functions thought to be lost in late-stage dementia, though it does not reverse the disease. 
